Published June 22, 2018 | Version v1
Dataset Open

Data from: Evaluation of exposure to effervescent drugs in a large health check-up population in France: a cross-sectional study

  • 1. Department of Pharmacy*
  • 2. Centre d'Investigations Préventives et Cliniques*
  • 3. Inserm

Description

OBJECTIVES: The relationship between high dietary sodium intake and hypertension is well established. Some drugs are associated with high-sodium content, particularly effervescent tablets (ETs). Despite a possible cardiovascular risk associated with the use of such drugs, observational data describing exposure to ETs in ambulatory subjects are lacking. The aim of this study was to estimate the prevalence of exposure to ETs, and to highlight factors associated with this exposure, in a large French health check-up population. DESIGN: This was cross-sectional study. SETTING AND PARTICIPANTS: Participants were French individuals who underwent medical check-ups at the Investigations Préventives et Cliniques center between April and June 2017. RESULTS: In total, 1,043 subjects were included in the study. The prevalence of exposure to ETs in the last 30 days was 26.9% (95% CI: 24.2 – 29.6). Exposure was frequent (i.e. two ETs per week or more in the last 30 days) for 7.3% of subjects. Self-medication was the major source of exposure (93.8%). Paracetamol, aspirin, vitamins, and betaine accounted for 95.3% of the ETs used. The factors associated with this exposure by multivariate analysis were: male gender, Overseas French origin, depression and body mass index ≥ 25 kg.m-2. A diagnosis of hypertension or treatment with diuretics were not protective factors against exposure to ETs. CONCLUSION: Exposure to ETs is frequent in the general population, particularly through self-medication. Clinical conditions associated with low-salt requirements were not associated with lower exposure to ETs, suggesting a lack of awareness by practitioners and patients about this iatrogenic issue.

Notes

Files

README_for_dataset_1.pdf

Files (957.7 kB)

Name Size Download all
md5:232b8cee09156c8bcc1ea0864cb06bc4
290.4 kB Download
md5:6ee65ecc0d6fcc9f05d9321a0a4e9f2e
67.4 kB Download
md5:f6cf946a69844332de39d8c53e0617eb
465.4 kB Download
md5:a5ba461f44b60047031fe40a48032139
48.4 kB Preview Download
md5:36c12b6c5dfd74cbe37ef92796571d43
36.1 kB Preview Download
md5:d9c67077e11d5e08709dc015ac47f71f
50.0 kB Preview Download

Additional details

Related works